TrialInvestigative and clinical urology2026

Intravesical mitomycin-C administered immediately before transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: Clinical outcomes and molecular predictors from over 3 years of extended follow-up in a phase II trial.

Hye Won Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.